Does surgery spread cervical cancer cells? new study investigates
NCT ID NCT04770090
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether surgery for early-stage cervical cancer causes tumor cells to enter the bloodstream, which might explain higher recurrence rates seen with certain surgical methods. Researchers will take blood samples from 20 women during their operation to detect circulating tumor cells. They will also track whether these women remain cancer-free for 3 to 5 years after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If tumor cells are found in the blood during surgery, it could help explain why some women have a higher risk of cancer returning after certain types of surgery.
What could go wrong
This is a small, early-stage observational study, so it may not prove that these cells cause recurrence. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER STAGE IB2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nîmes
Nîmes, France
-
Department of gynaecology, Montpellier University Hospital
Montpellier, 34295, France
-
Institut du Cancer de Montpellier - Val d'Aurelle
Montpellier, 34298, France